PXS Share Price Performance
UK£0.0062
0.00 (3.35%)
Price UK£0.0062
Share PriceUK£0.0062
We're Keeping An Eye On Provexis' (LON:PXS) Cash Burn Rate
Mar 05
Provexis plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PXS Community Narratives
There are no narratives available yet.
Provexis plc Key Details
Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0002
- Gross Margin
- 34.96%
- Net Profit Margin
- -39.86%
- Debt/Equity Ratio
- 0%
Provexis plc Competitors
Snowflake Analysis
About PXS
- Founded
- 1999
- Employees
- 2
- CEO
- WebsiteView website
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company’s website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.K. Market Performance
- 7 Days: 2.0%
- 3 Months: 7.1%
- 1 Year: 13.2%
- Year to Date: 14.5%
Over the last 7 days, the market has risen 2.0%, driven by gains of 10% in the Healthcare sector. As for the past 12 months, the market is up 13%. Looking forward, earnings are forecast to grow by 14% annually. Market details ›